The appointment by President-elect Trump of Robert F. Kennedy, Jr. as head of Health and Human Services may well be the political price he is forced to pay for an alliance that may have pushed his election over the top in some states where the margin was close.

But appointing an environmentalist activist attorney with no formal scientific or medical training, and a long history of promoting anti-vaccine conspiracy theories and HIV misinformation, is a very dangerous move. Kennedy’s hostility to both government (the FDA in particular) and industry (“big pharma”) can stifle scientific and medical inquiry, and the ongoing development and timely delivery of new vaccines and drug therapies — making Americans less healthy rather than more.

One month ago, "Big Pharma" (and the FDA’s approval process for new drugs) was there with space age drug-eluting stents, anticoagulants, and other medications to save my life, as well as being there several times through the years with medicines that again and again saved my life when I was desperately ill.

Kennedy’s intentions

Kennedy has some very legitimate concerns about the quality of our food supply, and the FDA has not always practiced fully its role in objective oversight. Reforms are needed.

Advertise with us

But when the HHS nominee has comments on X, like the following this past October, it is clear that he intends to make them with a wrecking ball, not a scalpel: "FDA's war on public health is about to end … If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."

It also doesn’t instill confidence that this is the man Trump told to, “Go wild,” on food and medicines.

Blaming "Big Pharma" for our health woes is asinine on a good day. It isn't the pharmaceutical industry's fault that we are obese, that we lead wickedly sedentary lifestyles, that we make all the wrong choices at the grocery store.

Not the industry’s fault

The pharmaceutical industry doesn't induce diabetes and clogged arteries. Our lifestyle choices do that. The industry does make medicines that lower blood glucose, and statin drugs that lower the body's production of artery-clogging cholesterol. It does make next generation drug-eluting stents for clogged coronary arteries that save and extend lives.

The pharmaceutical industry doesn't poison our environment with all manner of cancer-causing pollutants, but it does make generation after generation of newer, less toxic, more targeted chemotherapies.

Advertise with us

The pharmaceutical industry isn’t responsible for people’s sexual choices, but it does make antibiotics to cure bacterial STD's, makes antiviral medications to lessen the severity of Herpes, and turn HIV into a manageable, chronic infection, instead of the death sentence that it once was.

The pharmaceutical industry doesn't produce infectious diseases, but has saved billions of lives over the past 80 years with vaccines that are safe and effective, while Kennedy has spent years at the anti-vaccine advocacy group, Children’s Defense, undermining trust in the safety and efficacy of vaccines.

Kennedy infantilizes us by blaming "Big Pharma" for our being unhealthy, absolving us of our responsibility for how we got here. This is the very nanny state approach that Trump has long campaigned against.

Taking a wrecking ball to this industry, instead of the skillful use of a scalpel, can destroy investor confidence, wreck stocks, and collapse the industry. In the name of making us all healthier, Kennedy may well succeed in costing countless lives.

Reject Kennedy

Yes, the industry needs to be regulated, and yes, too often the government has failed to do that job well. Throwing the baby out with the bathwater is not the solution. The Senate needs to reject Kennedy, who might be better suited for working with Elon Musk and Vivek Ramaswamy in trimming government waste.

Advertise with us

Then Trump needs to appoint a physician, someone with both scientific as well as clinical expertise, who appreciates the contributions of the industry so much that he or she will ensure regulatory compliance and government accountability that will keep the best products flowing, and the most promising research in the basic and clinical sciences funded well into the future.

Gerard Nadal, a microbiologist, has taught at at St. John’s University and Manhattan College and now teaches at St. Paul’s School of Nursing in New York City.